Catalyst Wire Dossier Catalyst Wire Dossier

bevazizumab

bevacizumab · Genentech (as a reference product) / multiple manufacturers depending on market
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bevazizumab, covering 2020-11-04 to 2020-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Compare IBI305 and Bevacizumab on Pharmacokinetics/Safety/Immunogenicity on Healthy Male [Phase 1]

See pricing